Welcome to our dedicated page for Microvision SEC filings (Ticker: MVIS), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
This page provides access to MicroVision, Inc. (NASDAQ: MVIS) SEC filings, offering a centralized view of the company’s regulatory disclosures. Through these documents, investors can review how MicroVision reports on its lidar hardware and perception software business, its activities in automotive, industrial, and defense-related markets, and its corporate governance and financing arrangements.
Key filings for MicroVision include Form 10-K annual reports and Form 10-Q quarterly reports, which describe the company’s business, risk factors, and financial results. These reports are particularly relevant for understanding MicroVision’s investment in solid-state lidar technologies, its focus on ADAS and autonomous driving, and its efforts in industrial automation and defense tech. Current reports on Form 8-K provide timely updates on material events, such as leadership changes, executive compensation arrangements, board appointments, and the announcement of quarterly results.
MicroVision’s filings also document corporate actions like the appointment of a new Chief Executive Officer, the designation of an Executive Vice Chair, changes in board composition, and transitions in the Chief Financial Officer role. These disclosures help investors track how the company’s leadership and governance structure evolve alongside its strategic focus on autonomy and mobility.
On Stock Titan, MicroVision’s SEC documents are updated in near real time as they are posted to EDGAR. AI-powered summaries assist readers by highlighting the main points in lengthy filings, including key business updates, segment information where provided, and notable risk or governance items. Users can quickly scan 10-K and 10-Q reports, review 8-K announcements about material events, and access other filings while relying on AI-generated explanations to navigate complex regulatory language more efficiently.
MICROVISION, INC. CEO Glen W. DeVos reported routine equity compensation activity involving restricted stock units and related tax withholding. On March 31, 2026, 325,000 vested restricted stock units converted into an equal number of common shares. On April 2, 2026, the company completed a tax-related nondiscretionary sell-to-cover transaction, withholding 153,230 common shares at a weighted average price of $0.6403 per share in multiple trades between $0.6402 and $0.6408. Following these transactions, DeVos directly holds 359,670 shares of MicroVision common stock. The filing reflects compensation vesting and tax settlement rather than open-market buying or selling by the CEO.
The Vanguard Group filed Amendment No. 3 to Schedule 13G/A reporting 0 shares of MicroVision Inc. common stock as beneficially owned. The filing explains an internal realignment and disaggregation under SEC Release No. 34-39538 (January 12, 1998), with certain subsidiaries reporting separately. The amendment is signed by Ashley Grim on 03/27/2026.
MicroVision, Inc. Executive Vice Chair Simon Biddiscombe acquired 93,950 shares of the company’s common stock on March 15, 2026. The shares were purchased directly from MicroVision under a Subscription Agreement at $0.5322 per share, the closing price on March 13, 2026, in a transaction intended to be exempt under Rule 16b-3. Following this acquisition, Biddiscombe directly holds 385,249 MicroVision shares.
MicroVision director Jeffrey A. Herbst acquired 28,185 shares of common stock directly from the company at $0.5322 per share under a Subscription Agreement executed on March 15, 2026. The purchase price matched the closing share price on March 13, 2026 and is intended to qualify as an exempt transaction under Rule 16b-3. Following this acquisition, Herbst directly holds 258,912 shares of MicroVision common stock.
MicroVision director Robert Paul Carlile acquired additional shares of the company’s common stock. On March 15, he obtained 187,900 shares directly from MicroVision under a Subscription Agreement at $0.5322 per share, matching the March 13 closing price. This increased his direct holdings to 538,699 shares. The purchase is intended to qualify as an exempt transaction under Rule 16b-3, meaning it is structured within specific insider trading exemption rules rather than as an open-market trade.
MicroVision director Laura J. Peterson acquired 37,580 shares of common stock from the company under a subscription agreement. The shares were purchased directly from MicroVision at a price of $0.5322 per share, matching the closing price on March 13, 2026.
After this exempt Rule 16b-3 transaction, Peterson directly holds 91,596 MicroVision shares. This reflects a compensation-related or insider-aligned acquisition rather than an open-market trade.
MicroVision, Inc. CEO Glen W. DeVos reported an acquisition of company stock. On March 15, 2026, he acquired 187,900 shares of MicroVision common stock directly from the company at $0.5322 per share under a Subscription Agreement, matching the March 13, 2026 closing price.
Following this transaction, DeVos directly holds 187,900 shares. A footnote states the purchase is intended to be an exempt transaction pursuant to Rule 16b-3.
MicroVision director Jada Smith acquired 28,185 shares of common stock directly from the company in a subscription transaction. The shares were purchased at $0.5322 per share, matching the closing price of MicroVision stock on March 13, 2026.
After this grant/award acquisition, Smith directly owns 154,543 shares of MicroVision common stock. The company indicates the purchase is intended to qualify as an exempt transaction under Rule 16b-3, which governs certain insider transactions with the issuer.
MicroVision, Inc. general counsel Drew G. Markham acquired 9,395 shares of common stock directly from the company on March 15, 2026. The purchase price was $0.5322 per share, matching the closing price on March 13, 2026 as set by a subscription agreement.
Following this transaction, Markham directly holds 388,329 shares of MicroVision common stock. The company indicates the purchase is intended to qualify as an exempt transaction under Rule 16b-3, which generally covers certain insider transactions approved under specific governance procedures.
MicroVision, Inc. Interim CFO Stephen Hrynewich acquired 9,395 shares of common stock in a direct transaction with the company. The shares were purchased at $0.5322 per share, matching the closing price on March 13, 2026, under a Subscription Agreement executed on March 15, 2026.
After this acquisition, Hrynewich directly holds 172,092 shares of MicroVision common stock. The company indicates the purchase is intended to qualify as an exempt transaction under Rule 16b-3, which governs certain insider transactions for reporting and short-swing profit purposes.